Human OSGEP/GAMOS3/GCPL1 ORF/cDNA clone-Lentivirus plasmid (NM_017807)

Cat. No.: pGMLP004420
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human OSGEP/GAMOS3/GCPL1 Lentiviral expression plasmid for OSGEP lentivirus packaging, OSGEP lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.


Target products collection

Go to OSGEP/GAMOS3 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $582.24
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP004420
Gene Name OSGEP
Accession Number NM_017807
Gene ID 55644
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 1008 bp
Gene Alias GAMOS3,GCPL1,KAE1,OSGEP1,PRSMG1,TCS3
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCCGGCGGTGCTGGGTTTTGAAGGCAGCGCCAATAAGATTGGCGTGGGCGTGGTGCGGGATGGCAAGGTGCTGGCGAACCCGCGGCGGACTTACGTCACGCCTCCTGGCACAGGATTCCTTCCAGGTGATACAGCCAGGCATCACCGAGCTGTTATCCTAGACCTGCTGCAGGAGGCACTAACAGAGTCTGGATTAACCTCCCAGGATATCGACTGCATTGCATACACCAAGGGCCCTGGCATGGGTGCCCCACTGGTTTCTGTGGCTGTTGTGGCCCGTACTGTGGCCCAACTGTGGAATAAGCCATTGGTGGGTGTGAACCACTGTATAGGCCACATTGAGATGGGCCGCCTCATCACTGGAGCCACCAGCCCAACCGTGTTGTATGTGAGTGGAGGAAATACGCAGGTGATTGCATACTCGGAACATCGTTACCGTATCTTTGGGGAAACCATCGATATTGCAGTGGGTAATTGTCTGGATCGTTTTGCTCGAGTGCTGAAGATTTCTAACGACCCAAGTCCAGGATACAACATTGAACAGATGGCAAAGCGAGGCAAGAAGCTAGTTGAGCTGCCATACACTGTAAAGGGGATGGACGTCTCATTCTCAGGGATCCTGTCTTTCATTGAGGATGTAGCCCATCGGATGCTGGCCACAGGCGAGTGTACTCCTGAGGATCTGTGTTTCTCCCTGCAGGAAACTGTGTTTGCAATGCTGGTAGAGATCACAGAGCGAGCCATGGCACATTGTGGCTCCCAGGAGGCCCTCATTGTGGGAGGAGTGGGGTGTAATGTGAGGCTACAGGAGATGATGGCAACAATGTGCCAGGAACGTGGAGCCCGGCTTTTTGCTACAGATGAGAGATTCTGTATTGACAATGGAGCGATGATAGCCCAGGCTGGCTGGGAGATGTTTCGGGCTGGACACAGGACCCCACTCAGTGATTCTGGGGTTACACAGAGGTATCGGACAGATGAAGTAGAGGTGACCTGGAGGGACTAA
ORF Protein Sequence MPAVLGFEGSANKIGVGVVRDGKVLANPRRTYVTPPGTGFLPGDTARHHRAVILDLLQEALTESGLTSQDIDCIAYTKGPGMGAPLVSVAVVARTVAQLWNKPLVGVNHCIGHIEMGRLITGATSPTVLYVSGGNTQVIAYSEHRYRIFGETIDIAVGNCLDRFARVLKISNDPSPGYNIEQMAKRGKKLVELPYTVKGMDVSFSGILSFIEDVAHRMLATGECTPEDLCFSLQETVFAMLVEITERAMAHCGSQEALIVGGVGCNVRLQEMMATMCQERGARLFATDERFCIDNGAMIAQAGWEMFRAGHRTPLSDSGVTQRYRTDEVEVTWRD

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-MP2226-Ab Anti-OSGEP/ GAMOS3/ GCPL1 monoclonal antibody
    Target Antigen GM-Tg-g-MP2226-Ag OSGEP VLP (virus-like particle)
    ORF Viral Vector pGMLP004420 Human OSGEP Lentivirus plasmid
    ORF Viral Vector vGMLP004420 Human OSGEP Lentivirus particle


    Target information

    Target ID GM-MP2226
    Target Name OSGEP
    Gene ID 55644, 66246, 702512, 290028, 101101062, 100687555, 507512, 100058606
    Gene Symbol and Synonyms 1500019L24Rik,GAMOS3,GCPL-1,GCPL1,KAE1,OSGEP,OSGEP1,PRSMG1,TCS3
    Uniprot Accession Q9NPF4
    Uniprot Entry Name OSGEP_HUMAN
    Protein Sub-location Transmembrane Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000092094
    Target Classification Not Available

    Predicted to enable N(6)-L-threonylcarbamoyladenine synthase activity and metal ion binding activity. Involved in tRNA threonylcarbamoyladenosine modification. Located in cytoplasm; nuclear speck; and plasma membrane. Part of EKC/KEOPS complex. Implicated in Galloway-Mowat syndrome 3. [provided by Alliance of Genome Resources, Apr 2022]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.